NCT07441460
- Conditions
- Resectable HER2-positive Breast Cancer
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Resectable HER2-positive Breast Cancer
Explore clinical trials studying Resectable HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study